July 7, 2025

Corcept Therapeutics (CORT) Stock Analysis: A Biotech Gem with 91% Potential Upside

Corcept Therapeutics Incorporated (CORT), a prominent player in the biotechnology industry, has been capturing investor attention with its robust pipeline and significant growth potential. Headquartered in Redwood City, California, the..

Prestige Consumer Healthcare (PBH) Stock Analysis: Potential 10% Upside and Steady Revenue Growth for Savvy Investors

Prestige Consumer Healthcare Inc. (PBH), a notable player in the healthcare sector, specializes in the development, manufacturing, and marketing of over-the-counter (OTC) health and personal care products. With a diverse..

Vaxcyte, Inc. (PCVX) Stock Analysis: Unpacking a 278% Potential Upside in the Biotech Sector

Vaxcyte, Inc. (PCVX), a prominent player in the biotechnology sector, presents an intriguing opportunity for investors seeking exposure to innovative healthcare solutions. Specializing in the development of conjugate and novel..

Alkermes plc (ALKS) Stock Analysis: Analyst Consensus Points to 42% Upside Potential

Alkermes plc (NASDAQ: ALKS), an Irish biopharmaceutical giant, is capturing the attention of investors with a compelling narrative. Operating within the Healthcare sector, specifically among Drug Manufacturers – Specialty &..

Biogen Inc. (BIIB) Investor Outlook: Analyzing a 29.60% Potential Upside Amidst Strong Analyst Support

Biogen Inc. (NASDAQ: BIIB), a towering figure in the healthcare sector with a market cap of $19.47 billion, offers investors a compelling opportunity with a potential upside of 29.60% based..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 27.08% Potential Upside in the Healthcare Sector

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, is gaining attention from investors due to its promising growth prospects and robust position within the medical devices industry...

Legend Biotech Corporation (LEGN) Stock Analysis: Unpacking a 114% Potential Upside in the CAR-T Space

Legend Biotech Corporation (NASDAQ: LEGN) is positioned at the forefront of the biotechnology sector with its innovative focus on cell therapies for oncology. With a market capitalization of $6.56 billion,..

Gilead Sciences, Inc. (GILD)

⚠️ No article content returned.

..

Avantor, Inc. (AVTR) Stock Analysis: Unpacking the 21.93% Potential Upside

Avantor, Inc. (NYSE: AVTR), a prominent player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $9.46 billion, Avantor specializes in providing..

Illumina, Inc. (ILMN) Stock Analysis: Exploring a 8.15% Upside in the Genomics Powerhouse

Illumina, Inc. (ILMN) stands as a pivotal entity in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $15.96 billion, Illumina is a trailblazer..

Bio-Techne Corp (TECH) Stock Analysis: Analyst Ratings Highlight 26.61% Potential Upside

Bio-Techne Corp (NASDAQ: TECH), a leading player in the biotechnology sector, has captured investor attention with its robust market presence and promising growth potential. With a market capitalization of $8.33..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Exploring a 92.52% Potential Upside in the Biotech Sector

Investors with an eye on the biotechnology sector should take a closer look at Revolution Medicines, Inc. (NASDAQ: RVMD), a clinical-stage precision oncology company that is drawing significant attention in..

ResMed Inc. (RMD) Stock Analysis: Navigating a 2.93% Potential Upside in the Healthcare Sector

ResMed Inc. (NYSE: RMD), a leading player in the healthcare sector, is capturing the attention of investors with a market cap of $37.68 billion and a robust portfolio of medical..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unveiling a Promising 41% Potential Upside

Telix Pharmaceuticals Limited (TLX) is emerging as a compelling player in the biotechnology sector, with its promising portfolio of radiopharmaceutical products and impressive market performance. Based in North Melbourne, Australia,..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: A 25% Potential Upside in the Healthcare Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO), a stalwart in the healthcare sector specializing in medical devices, offers an intriguing opportunity for investors with a potential upside of 25.35% according to analysts’..

Hologic, Inc. (HOLX) Stock Analysis: Evaluating the 3.85% Potential Upside in the Healthcare Sector

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, is making waves with its strategic focus on women’s health and its diversified portfolio of diagnostics, medical imaging, and..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: A 66% Upside Potential Amid Strong Analyst Ratings

For investors with an eye on the biotechnology sector, BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) offers a compelling opportunity. With a market capitalization of $11.03 billion, BioMarin stands as a significant..

Qiagen N.V. (QGEN) Stock Analysis: A Promising 3.71% Upside Potential for Investors

Qiagen N.V. (QGEN), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, offers an intriguing proposition for investors eyeing steady growth and innovative healthcare solutions...

Haleon plc (HLN) Stock Analysis: Exploring a 12.76% Potential Upside and Robust Market Cap

Haleon plc (HLN), a stalwart in the healthcare sector, commands significant attention from investors with its market cap standing robustly at $46.04 billion. As a prominent player in the Drug..

Encompass Health Corporation (EHC) Stock Analysis: A 10.54% Upside Awaits Investors in the Healthcare Sector

Encompass Health Corporation (NYSE: EHC), a leading provider of post-acute healthcare services, has captured investor attention with an enticing potential upside of 10.54%. With its market capitalization standing at a..

Search

Funds

July 7, 2025

Search

Funds

July 7, 2025

FTSE 100

Funds